Johnson & Johnson (JNJ) is in talks to acquire Shockwave Medical (SWAV) and a deal could be finalized in the coming weeks, Lauren Thomas and Laura Cooper of Wall Street Journal report, citing people familiar with the matter. It is also possible another suitor could emerge, the Journal adds. Shares of Shockwave jumped 8% to $311.29 following the report before being halted for volatility.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SWAV:
- Shockwave Medical to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- ShockWave Medical price target raised to $310 from $275 at BofA
- ShockWave Medical price target raised to $286 from $260 at Needham
- ShockWave Medical price target raised to $290 from $275 at Piper Sandler
- ShockWave Medical price target raised to $263 from $215 at Canaccord
